• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-异丙基-p-[123I]碘安非他明在灵长类动物中的生物分布与剂量测定

Biodistribution and dosimetry of N-isopropyl-p-[123I]iodoamphetamine in the primate.

作者信息

Holman B L, Zimmerman R E, Schapiro J R, Kaplan M L, Jones A G, Hill T C

出版信息

J Nucl Med. 1983 Oct;24(10):922-31.

PMID:6619962
Abstract

The biodistribution of N-isopropyl-p-[123I]iodoamphetamine (I-123 IMP) in the Macaca fascicularis monkey was determined at 15 min and at 1, 4, 24, and 48 hr after intravenous injection. Brain uptake was 7.8% of the injected dose at 1 hr, with little change in concentration between 15 min and 1 hr, falling thereafter. Eye uptake reached a maximum of 0.23% of injected dose at 24 hr, with activity primarily in the pigmented layers. The human absorbed radiation dose was calculated on the basis of biodistribution data. The critical organ is the eye (0.407 rad/mCi of I-123 IMP). The eye dose increased to 1.11 rad/mCi with 4% contamination from I-124 IMP and to 0.535 rad/mCi with 0.4% contamination from I-125 IMP. The absorbed dose to the liver was 0.127 rad/mCi for pure I-123 IMP and the thyroid dose was 0.120 rad/mCi, both increasing with either I-124 or I-125 contamination. While delayed eye uptake has not yet been reported in the human, care should be exercised in limiting the amount of contaminating I-124 or I-125 to the lowest practical level.

摘要

在食蟹猴静脉注射 N-异丙基-p-[¹²³I]碘安非他明(I-123 IMP)后 15 分钟以及 1、4、24 和 48 小时,测定了其生物分布。1 小时时脑摄取量为注射剂量的 7.8%,15 分钟至 1 小时之间浓度变化不大,此后下降。眼部摄取在 24 小时时达到注射剂量的 0.23%最大值,活性主要在色素层。根据生物分布数据计算了人体吸收辐射剂量。关键器官是眼睛(I-123 IMP 为 0.407 拉德/毫居里)。当含有 4%的 I-124 IMP 污染时,眼部剂量增加到 1.11 拉德/毫居里;当含有 0.4%的 I-125 IMP 污染时,眼部剂量增加到 0.535 拉德/毫居里。纯 I-123 IMP 时肝脏吸收剂量为 0.127 拉德/毫居里,甲状腺剂量为 0.120 拉德/毫居里,二者都会因 I-124 或 I-125 污染而增加。虽然尚未在人体中报道过延迟的眼部摄取情况,但应谨慎将 I-124 或 I-125 的污染量限制在实际可行的最低水平。

相似文献

1
Biodistribution and dosimetry of N-isopropyl-p-[123I]iodoamphetamine in the primate.N-异丙基-p-[123I]碘安非他明在灵长类动物中的生物分布与剂量测定
J Nucl Med. 1983 Oct;24(10):922-31.
2
Effect of antidepressant and narcoleptic drugs on N-isopropyl p-iodoamphetamine biodistribution in animals.抗抑郁药和发作性睡病药物对动物体内 N-异丙基对碘安非他明生物分布的影响。
J Nucl Med. 1987 Mar;28(3):354-9.
3
The relationship of the eye uptake of N-isopropyl-p-[123I]iodoamphetamine to melanin production.
J Nucl Med. 1984 Mar;25(3):315-9.
4
Biodistribution of N-isopropyl-p-iodoamphetamine in the rat brain.N-异丙基-对-碘安非他明在大鼠脑中的生物分布。
Nuklearmedizin. 1987 Jun;26(3):131-4.
5
Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.正电子发射断层扫描灌注剂铜-62-双硫辛酸甲酯的人体生物分布与剂量测定
J Nucl Med. 1998 Nov;39(11):1958-64.
6
Demonstration and quantitation of pharmacological inhibition of pulmonary uptake of N-isopropyl-123I-p-iodoamphetamine by propranolol.普萘洛尔对 N-异丙基-123I-对碘安非他明肺摄取的药理抑制作用的演示与定量分析。
Nuklearmedizin. 1989 Jun;28(3):100-4.
7
Biodistribution and dosimetry of indium-111-polyclonal IgG in normal subjects.铟-111标记多克隆IgG在正常受试者体内的生物分布与剂量测定
J Nucl Med. 1995 Dec;36(12):2372-9.
8
Thallium-201 diethyldithiocarbamate: an alternative to iodine-123 N-isopropyl-p-iodoamphetamine.
J Nucl Med. 1985 Aug;26(8):925-30.
9
In vivo chemistry of iofetamine HCl iodine-123 (IMP).盐酸碘苯酯-123(IMP)的体内化学。
J Nucl Med. 1988 Jan;29(1):122-4.
10
Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand.碘-123-表哌立得的剂量学:一种多巴胺D2受体配体
J Nucl Med. 1995 Jul;36(7):1316-21.

引用本文的文献

1
Noninvasive diagnostics supporting system for choroidal melanoma: a pilot study.脉络膜黑色素瘤的非侵入性诊断支持系统:一项初步研究。
Jpn J Ophthalmol. 2015 Jan;59(1):48-54. doi: 10.1007/s10384-014-0351-3. Epub 2014 Oct 8.
2
Localization of IBF as a D-2 dopamine receptor imaging agent in nonhuman primates.
Eur J Nucl Med. 1993 Dec;20(12):1146-53. doi: 10.1007/BF00171012.
3
Evaluation of portal circulation through the superior mesenteric vein with an enteric capsule of [123I]iodoamphetamine.
J Gastroenterol. 1995 Feb;30(1):55-60. doi: 10.1007/BF01211375.
4
Localization of melanoma with radiolabelled monoclonal antibody fragments and iodoamphetamine.用放射性标记的单克隆抗体片段和碘安非他明对黑色素瘤进行定位。
Eur J Nucl Med. 1986;12(7):359-62. doi: 10.1007/BF00263821.
5
N-isopropyl-p[123I]iodoamphetamine, a new agent for lung imaging studies.N-异丙基-p[123I]碘安非他明,一种用于肺部成像研究的新型试剂。
Thorax. 1986 Oct;41(10):801-3. doi: 10.1136/thx.41.10.801.
6
Brain affinity of the ruthenocene analogue of N-isopropyl-amphetamine labeled with gamma-emitters.用γ发射体标记的N-异丙基苯丙胺的二茂钌类似物的脑亲和性。
Naturwissenschaften. 1986 Aug;73(8):509-10. doi: 10.1007/BF00367203.
7
Early and delayed single photon emission CT in various cerebral diseases using N-isopropyl-p-(123I)iodoamphetamine.使用N-异丙基-p-(123I)碘安非他明对各种脑部疾病进行早期和延迟单光子发射计算机断层扫描
Neuroradiology. 1988;30(2):123-31. doi: 10.1007/BF00395613.
8
Prolonged lung retention of 123I-IMP in pulmonary disease.123I-异碘普胺在肺部疾病中的肺内滞留时间延长。
Eur J Nucl Med. 1989;15(10):646-8. doi: 10.1007/BF00251677.
9
The influence of age on N-isopropyl-p-[123I]iodoamphetamine accumulation in the human heart.年龄对 N-异丙基-p-[123I]碘安非他明在人心脏中蓄积的影响。
Ann Nucl Med. 1990 Jul;4(2):49-54. doi: 10.1007/BF03164595.
10
Change of accumulation and filling pattern in evolution of cerebral infarction with I-123 IMP brain SPECT.I-123 IMP脑SPECT观察脑梗死演变过程中放射性药物积聚及填充模式的变化
Neuroradiology. 1991;33(1):9-14. doi: 10.1007/BF00593325.